TSLA
Tesla
-- 421.060 PLTR
Palantir
-- 80.550 NVDA
NVIDIA
-- 134.700 OXY
Occidental Petroleum
-- 47.130 AMD
Advanced Micro Devices
-- 119.210 
NEWS
3D Systems Expands Orthopedic Surgical Planning Portfolio Receiving FDA Clearance for Key Ankle Indications
3D Systems (NYSE:DDD) has received FDA 510(k) clearance for its TOTAL ANKLE Patient-Matched Guides, designed to work with Smith+Nephew's total ankle replacement solutions. This expansion of 3D Systems' orthopedic surgical planning portfolio leverages the company's VSP surgical planning workflows and advanced 3D printing technologies. The patient-specific guides aim to improve surgical efficiency and accuracy while reducing procedural steps and operating room time.
Key highlights include:
Over 175,000 patient-matched cases supported
Collaboration with Smith+Nephew for tailored total ankle replacement surgery
Potential for reduced intraoperative x-ray radiation
Expansion into large joint and trauma applications
Growing orthopedic devices market, anticipated to reach $5.3 billion by 2032
Key highlights include:
Over 175,000 patient-matched cases supported
Collaboration with Smith+Nephew for tailored total ankle replacement surgery
Potential for reduced intraoperative x-ray radiation
Expansion into large joint and trauma applications
Growing orthopedic devices market, anticipated to reach $5.3 billion by 2032
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment